A recent study has found that just more than 30 percent of people with cancer in Germany also experienced some form of clinically relevant mental health disorder. The article, published…
Read More
By Rachel Sass, PharmD What is your perception of a pharmacist? Someone in a white coat at the local pharmacy who fills your prescriptions, answers your questions and helps you…
Read More
For the third time since Genelex was founded, the Seattle-based company leading the way in DNA sensitivity testing to help combat adverse drug events has been named one of Washington’s…
Read More
Genelex's Pharmacy Team from left to right: Jennifer Jepsen, PharmD; Derry McDonald; John Hodges; Tyler Mamiya, PharmD; Richard Newman; Valerie Fishbeck, PharmD; and Rachel Sass, PharmD. Not pictured are PharmDs…
Read More
The federal government has placed new restrictions on the prescribing of medications containing the opioid hydrocodone. Effective Oct. 6, the U.S. Drug Enforcement Agency (DEA) has published a final rule…
Read More
Genelex’s progress toward eliminating adverse drug events has been honored by Seattle Business magazine with a 2014 Tech Impact Award. At the September 18 awards event, Genelex was given the…
Read More
Health care providers have been granted a bit of flexibility in how they use certified electronic health records (EHR) technology in meeting federal Meaningful Use requirements for 2014. The Centers…
Read More
A recent study illuminates the prevalence of opioid painkiller use in a particularly vulnerable population: disabled Americans on Social Security disability insurance. The article, published in the September edition of…
Read More
The use of health information technology enhancements, such as clinical decision support tools, can help reduce adverse drug events (ADEs) in hospitals by between 27.3 and 69.2 percent, according to…
Read More
New research into the risks of three common antipsychotic drugs for the elderly suggests older patients are 73 percent more likely to experience acute kidney injury (AKI) while on any…
Read More
